Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Krishna Phoschem Limited. The discussion focuses on capacity utilization, expansion, and expected revenues but does not specify order backlog details. Management emphasizes strong production volumes and healthy channel inventory, indicating stable demand. They highlight completed capacity expansion and ongoing efforts for future projects, but no specific backlog figures are given. Cash flow and receivables related queries suggest demand is being met without bottlenecks. Overall, no quantifiable

Future growth expectations in sales/revenue/volumes?

FY27 revenue growth expected at 35%-40%, driven by capacity utilization and imports. Top-line increase of around Rs. 500 crore anticipated from a 50% increase in NPK/DAP capacity (approx. 80,000 tons increase × Rs. 60,000 per ton). Manufacturing volumes for FY26 were approx. 383,000 MT and trading volumes approx. 93,000 MT; growth expected with stable or increased volumes in FY27. Capacity expansion commenced in April FY27; full utilization expected after initial quarter. Trading sales are expected to continue to complement manufacturing with around Rs.1,000 crore in imports projected

Any current/future new fundraising through debt or equity?

No specific new fundraising through debt or equity has been declared or announced as of now. The company mentions working on various projects and expansions but states that any capital expenditure (CAPEX) plans will be communicated only after regulatory approvals. They emphasize declaring CAPEX at appropriate times with a proper debt-equity ratio to support expansion. The management highlights having very good cash flow and maintaining financial strength (supported by CRISIL A+ Stable credit rating). No additional capital raises are planned in the near term; current focus is on utilizi

Any current/future capex/capital investment/strategic investment?

The Company has recently completed a significant capacity expansion: NPK/DAP capacity increased by 50% to 495,000 MTPA, SSP capacity at 120,000 MTPA, totaling 615,000 MTPA phosphatic fertilizer capacity. Backward integration strengthened with sulphuric acid capacity of 99,000 MTPA. Green Ammonia Sale Agreement (GASA) for 70,000 MTPA under the National Green Hydrogen Mission, with green ammonia expected to start supply after approximately three years. No additional capex or expansion plans have been declared beyond the current expansion. Management indicated that they keep planning business exp

Future growth expectations in earnings/operating earnings/profits/EPS?

FY27 revenue growth expected at 35%-40%, led by capacity expansion and increased manufacturing plus imports. Topline increase of ~Rs.500 crore projected from 165,000 tons capacity addition, reaching Rs.2,900-3,000 crore revenue range. EBITDA margins may face pressure in FY27 due to higher input costs (e.g., sulfur), but the company aims to sustain reasonable profitability through a mix of government subsidies and MRP price adjustments. Management is committed to maintaining profitability; however, Q1 FY27 may have margin moderation with expected stabilization in later quarters. EPS gro

IN US

Sale is live|00:00:00left today

Krishana Phoschem LtdQ1 FY26Fertilizers & Agrochemicals

Krishana Phoschem Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹727P/E: 22.5Market Cap: ₹4.1K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 1

Margin

Category 4

Fundraise

N/A

Order

N/A

Capex

N/A

1 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 1

→FY27 revenue growth expected at 35%-40%, driven by capacity utilization and imports.
→Top-line increase of around Rs. 500 crore anticipated from a 50% increase in NPK/DAP capacity (approx. 80,000 tons increase × Rs. 60,000 per ton).
→Manufacturing volumes for FY26 were approx. 383,000 MT and trading volumes approx. 93,000 MT; growth expected with stable or increased volumes in FY27.
→Capacity expansion commenced in April FY27; full utilization expected after initial quarter.
→Trading sales are expected to continue to complement manufacturing with around Rs.1,000 crore in imports projected for FY27.
→Margins may face some pressure due to rising input costs but profitability to be sustained through price adjustments and government subsidies.
→The company remains committed to maintaining performance and achieving growth with improved scale and operating leverage.

Margin guidance

Category 4

→FY27 revenue growth expected at 35%-40%, led by capacity expansion and increased manufacturing plus imports.
→Topline increase of ~Rs.500 crore projected from 165,000 tons capacity addition, reaching Rs.2,900-3,000 crore revenue range.
→EBITDA margins may face pressure in FY27 due to higher input costs (e.g., sulfur), but the company aims to sustain reasonable profitability through a mix of government subsidies and MRP price adjustments.
→Management is committed to maintaining profitability; however, Q1 FY27 may have margin moderation with expected stabilization in later quarters.
→EPS growth momentum is anticipated to continue consistent with revenue and profit growth, supported by operational efficiencies and financial management.
→Long-term growth supported by integration initiatives and sustainability projects like Green Ammonia, enhancing value creation.
→No definitive CAPEX plans declared for FY27 as company awaits regulatory approval, focusing on efficient utilization of current capacity.

3 more insights locked — sign up free to unlock

Fundraise plans

→No specific new fundraising through debt or equity has been declared or announced as of now.
→The company mentions working on various projects and expansions but states that any capital expenditure (CAPEX) plans will be communicated only after regulatory approvals.
→They emphasize declaring CAPEX at appropriate times with a proper debt-equity ratio to support expansion.
→The management highlights having very good cash flow and maintaining financial strength (supported by CRISIL A+ Stable credit rating).
→No additional capital raises are planned in the near term; current focus is on utilizing existing capacity expansions and managing working capital efficiently.
→Investor updates regarding any future expansions or fundraising will be provided when finalized and approved by regulators.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders for Krishna Phoschem Limited.
→The discussion focuses on capacity utilization, expansion, and expected revenues but does not specify order backlog details.
→Management emphasizes strong production volumes and healthy channel inventory, indicating stable demand.
→They highlight completed capacity expansion and ongoing efforts for future projects, but no specific backlog figures are given.
→Cash flow and receivables related queries suggest demand is being met without bottlenecks.
→Overall, no quantifiable order book or pending orders data is provided in the Q4 FY26 earnings call transcript.

Capex plans

→The Company has recently completed a significant capacity expansion: NPK/DAP capacity increased by 50% to 495,000 MTPA, SSP capacity at 120,000 MTPA, totaling 615,000 MTPA phosphatic fertilizer capacity.
→Backward integration strengthened with sulphuric acid capacity of 99,000 MTPA.
→Green Ammonia Sale Agreement (GASA) for 70,000 MTPA under the National Green Hydrogen Mission, with green ammonia expected to start supply after approximately three years.
→No additional capex or expansion plans have been declared beyond the current expansion.
→Management indicated that they keep planning business expansions and will update investors after regulatory declarations.
→FY27 capex estimates are not disclosed yet due to pending statutory approvals.
→The company maintains a disciplined capital allocation funded through internal accruals and term loans.
→Overall, future capex is under evaluation, with new projects being worked on but no firm announcements yet.

How does Krishana Phoschem Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Krishana Phoschem Ltd

Rev 1Mar 4

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Krishana Phoschem Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio